• Home
  • Crypto Market
  • Nifty Pharma Index Records a 1.57% Decline in Latest Stock Market Update
Nifty Pharma Index Records a 1.57% Decline in Latest Stock Market Update

Nifty Pharma Index Records a 1.57% Decline in Latest Stock Market Update

The Nifty Pharma Index Closes in Negative Territory

The Nifty Pharma index closed with a negative performance on Thursday. Among the top gainers were Granules India Ltd., Sanofi India Ltd., and Pfizer Ltd. On the other hand, Cipla Ltd., Aurobindo Pharma Ltd., Ipca Laboratories Ltd., Lupin Ltd., and Zydus Lifesciences Ltd. finished as the top losers of the day.

The Nifty Pharma index ended the day down by 1.57 percent at 15817.45. The benchmark NSE Nifty50 index closed down by 9.85 points at 19802.0, while the BSE Sensex stood down by 5.43 points at 66017.81.

Stock Performance in the Nifty Index

Out of the 50 stocks in the Nifty index, 23 ended in the green, while 25 closed in the red.

Most Traded Shares and Fresh 52-Week Highs/Lows

Shares of YES Bank, Vodafone Idea, JP Power, Reliance Power, and Suzlon Energy were among the most traded shares on the NSE. Honasa Consumer, 3i Infotech, Syncom Form, Avadh Sugar Energy, and Intense Tech hit their fresh 52-week highs in today’s trade, while Shaily Engg Pla, Bohra Industries, Lords Chloro, SEL Manufact, and Fourth Dimension Sol hit their fresh 52-week lows.

Hot Take: Market Volatility Continues with Pharma Stocks Leading the Way

Pharmaceutical stocks had a mixed day in the market as some gained while others experienced losses. The overall sentiment in the market remained cautious as reflected in the negative performance of the Nifty Pharma index. Investors need to closely monitor the market and make informed decisions based on the performance of individual stocks. It is advisable to diversify your portfolio to minimize risks and take advantage of opportunities in different sectors. Stay updated with the latest market trends and news to make well-informed investment choices.

Read Disclaimer
This content is aimed at sharing knowledge, it's not a direct proposal to transact, nor a prompt to engage in offers. Lolacoin.org doesn't provide expert advice regarding finance, tax, or legal matters. Caveat emptor applies when you utilize any products, services, or materials described in this post. In every interpretation of the law, either directly or by virtue of any negligence, neither our team nor the poster bears responsibility for any detriment or loss resulting. Dive into the details on Critical Disclaimers and Risk Disclosures.

Share it

Nifty Pharma Index Records a 1.57% Decline in Latest Stock Market Update